Medical management of inflammatory bowel disease: Old and new perspectives

Current Opinion in Gastroenterology

Volumn 17, Issue 4, 2001, Pages 336-341

  Nash, C L ^a   Sutherland, L R ^a  

^a FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOSALICYLIC ACID; AZATHIOPRINE; BUTYRIC ACID; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; CYCLOSPORIN; GROWTH HORMONE; HEPARIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INFLIXIMAB; INTERLEUKIN 2 RECEPTOR; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SALAZOSULFAPYRIDINE; THIOPURINE METHYLTRANSFERASE; TIOGUANINE;

BONE MARROW SUPPRESSION; CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; HEALTH CARE COST; HUMAN; LIVER TOXICITY; PANCREATITIS; PLASMAPHERESIS; REMISSION; REVIEW; SIDE EFFECT; ULCERATIVE COLITIS;

EID: 0034944269     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200107000-00007     Document Type: Review

References (39)

1. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital
2. Annual cost of care for Crohn's disease: A payor perspective
3. Rectal aminosalicylate therapy for distal ulcerative colitis: A meta-analysis
4. Rectal corticosteroids versus alternative treatments in ulcerative colitis: A meta-analysis
5. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: A study to determine the active therapeutic moiety of sulphasalazine
6. Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis
7. Oral 5-aminosalicylic acid for inducing remission in ulcerative colitis
8. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: A 12-month pilot study
9. Cyclosporin in severe ulcerative colitis refractory to steroid therapy
10. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis
11. Combined oral sodium butyrate and mesalazine treatment compared with oral mesalazine alone in ulcerative colitis: Randomized, double-blind, placebo-controlled pilot study
12. Preliminary experience with plasma exchange in patients with ulcerative colitis
13. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease
14. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis
15. The course and prognosis of ulcerative colitis. 1. Short-term prognosis
16. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis
17. Oral 5-aminosalicylic acid for maintaining remission in ulcerative colitis
18. Allopurinol in addition to 5-amino-salicylic acid based drugs for the maintenance treatment of ulcerative colitis
19. Azathioprine and 6-mercaptopurine in Crohn's disease: A meta-analysis
20. 6-Mercaptopurine metabolites in Crohn's disease: Correlation with efficacy and toxicity
21. Pharmacogenomics and metabolite measurement of 6-mercaptopurine therapy in inflammatory bowel disease
22. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
23. Randomized trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
24. Mycophenolate mofetil in patients with Crohn's disease
25. Mycophenolate mofetil in Crohn's disease
26. Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
27. A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis
28. National Cooperative Crohn's Disease Study: Results of drug treatment
29. Open label trial of oral clarithromycin in active Crohn's disease
30. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease
31. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease
32. A preliminary study of growth hormone therapy for Crohn's disease
33. Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding
34. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
35. Mesalamine for the prevention of postoperative recurrence: Is nearly there the same as being there?
36. Mesalamine and relapse prevention in Crohn's disease
37. Azathioprine for maintaining remission of Crohn's disease
38. Methotrexate in Crohn's disease: Long term efficacy and toxicity
39. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease